Imugene Limited
IUGNFOTCHealthcare● Active
$0.10
$-0.00(-0.48%)
Market Cap$43454758
P/E Ratio—
52W High$0.646
52W Low$0.059
Imugene Limited（IUGNF）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · IUGNF · 截至 Jun 9, 2026
关键指标
探索 Imugene Limited 数据
iugnf stock data · financials财务快照
完整财报FY 2025Revenue$4.4M▼ 11.53% YoY
202320242025
imugene limited revenue · iugnf revenue 2025FY 2025Net Income-$69.0M▲ +53.89% YoY
202320242025
imugene limited net income · iugnf profit 2025FY 2025EPS$-0.32▲ +55.56% YoY
202320242025
iugnf eps · imugene limited earnings per share 2025竞争对手与同行
iugnf competitors#TickerCompanyPriceChangeMkt Cap
#1IUGNFImugene Limited
$0.10-0.48%$43.5M#2
BSEMBioStem Technologies, Inc.
$3.68-5.54%$62.5M#3
CLTEFCalliditas Therapeutics Ab
$0.33-52.81%$19.8M#4
HSCHFH-Source Holdings Ltd.
$0.00+0.00%$1,176#5
KNTPFKintor Pharmaceutical Limited
$0.57+110.58%$265.0M#6
MSCLFSatellos Bioscience Inc.
$6.25+11.81%$96.6M股票表现
完整历史1D-0.48%
1W+20.81%
1M+16.11%
3M-40.46%
YTD-59.81%
1Y-74.17%
5Y-98.69%
关于 Imugene Limited
Imugene Limited an Australian firm specializing in clinical-stage immuno-oncology, is dedicated to conceiving diverse immunotherapies. Its core mission involves activating the immune systems of cance…
what is imugene limited · iugnf stock overview · imugene limited company profile · who is imugene limited ceo · iugnf OTC · imugene limited headquarters · imugene limited business segments
关于股票概览与关键数据
Imugene Limited（IUGNF）是 Biotechnology 行业的 Healthcare 类公司，于 Jul 5, 2019 在 OTC 上市。截至最近交易日，IUGNF 股价为 $0.10，市值约为 $43.5M。过去12个月累计回报 -74.17%，年初至今回报 -59.81%。
2025 财年 Imugene Limited 营收 $4.4M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Imugene Limited（IUGNF）股价为 $0.10，在 OTC 上市，52周区间为 $0.06 – $0.65。
IUGNF 最新股价IUGNF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 9, 2026本内容不构成投资建议